David James Pinato 🇺🇦(@DJPinato) 's Twitter Profileg
David James Pinato 🇺🇦

@DJPinato

Medical Oncologist, MD PhD, Director of Developmental Therapeutics @ImperialCollege & @UniAvogadro ❤️ HCC, Immunotherapy and drug development. 🇮🇹 🇬🇧 🏳️‍🌈

ID:726462906813059073

calendar_today30-04-2016 17:27:08

1,4K Tweet

2,2K Takipçi

1,4K Takip Edilen

Journal for ImmunoTherapy of Cancer(@jitcancer) 's Twitter Profile Photo

New position article and guidelines: SITC recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease jitc.bmj.com/content/12/4/e… Jason Luke, MD, FACP Diwakar Davar, M.D. Joshua Brody, MD Greg Goldmacher Howard Kaufman Sherene Loi, MD

New #JITC position article and guidelines: SITC recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease jitc.bmj.com/content/12/4/e… @jasonlukemd @diwakardavar @JoshuaBrodyMD @greg_goldmacher @HowardK39084949 @LoiSher…
account_circle
Francesco Giganti(@giga_fra) 's Twitter Profile Photo

Thank you Society of Abdominal Radiology | SAR Andrei Purysko Sandeep Arora and rest of the outstanding faculty! Honoured to be here for the first workshop testing out PRECISE v2, just hot off the press!Open access here: sciencedirect.com/science/articl…. Spread the word! 🗣️🤝🌎

account_circle
Federico Rossari(@f_rossari) 's Twitter Profile Photo

Big team effort and important achievement for the group! andrea casadei gardini and Margherita Rimini simply pivotal in orchestrating such a collaborative network 🙏
Check out our new paper in Gastroenterology | Karger ⬇️

account_circle
Debbie Shawcross(@DebbieShawcros1) 's Twitter Profile Photo

This is a shattering read for any clinician who has their sights on a career in clinical academia in the UK which is hurtling towards extinction. 🦤
⚠️ 36% of CAs are aged >55
⚠️ 65% at Professor grade >55
⚠️<1% Black/Black British
⚠️ 76% of CAs are men
medschools.ac.uk/news/investmen…

account_circle
David James Pinato 🇺🇦(@DJPinato) 's Twitter Profile Photo

I am very grateful for the invite ESMO - Eur. Oncology to discuss immunotherapy and immunosuppression - much more work is required to broaden the reach of immunotherapy in special populations Surgery and Cancer UPO - Università

#ELCC24 I am very grateful for the invite @myESMO to discuss immunotherapy and immunosuppression - much more work is required to broaden the reach of immunotherapy in special populations @ImperialSandC @UniAvogadro
account_circle